Which hedge funds own ANRO? ALTO NEUROSCIENCE INC, Q2 2026 13F holders
26 tracked hedge funds disclosed a position in ANRO (ALTO NEUROSCIENCE INC) in their Q2 2026 13F filings, worth $474.5m in total. The largest holder by portfolio weight is Spruce Street Capital LP at 7.0% of its book. 3 opened a new position this quarter: Parkman Healthcare Partners LLC, Persistent Asset Partners Ltd, Schonfeld Strategic Advisors LLC. 12 exited: Almitas Capital LLC, 683 Capital Management, LLC, Diametric Capital, LP.
- 26
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 3
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 12
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $18.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $12.8m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $474m
- Combined value Sum of the holders' reported positions in the security.
- 2.1%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Almitas Capital LLC | 0.4% | $1.8m |
| 683 Capital Management, LLC | 0.08% | $899k |
| Diametric Capital, LP | 0.06% | $232k |
| Catalyst Funds Management Pty Ltd | 0.04% | $256k |
| Landscape Capital Management, L.L.C. | 0.03% | $407k |
| Y-Intercept (Hong Kong) Ltd | 0.01% | $538k |
| Brevan Howard Capital Management LP | 0.01% | $872k |
| Qube Research & Technologies Ltd | 0.01% | $4.7m |
| Hudson Bay Capital Management LP | 0.01% | $984k |
| Polen Capital | 0.0% | $373k |
| Balyasny Asset Management L.P. | 0.0% | $722k |
| D. E. Shaw & Co., Inc. | 0.0% | $1.0m |
Ownership over time
Who discovered ANRO first? Beta
| Commodore Capital LP | Q4 2025 | +1.2 pts |
| Vestal Point Capital, LP | Q4 2025 | +0.8 pts |
| Ikarian Capital, LLC | Q4 2025 | +0.8 pts |
| Affinity Asset Advisors, LLC | Q1 2026 | +0.1 pts |
| Philadelphia Financial Management of San Francisco, LLC | Q1 2024 | −0.3 pts |
| Alpha Wave Global, LP high conviction | Q1 2024 | −6.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.